| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/25/2007 | CN101006092A Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| 07/25/2007 | CN101005850A Methods of using apo2l receptor agonists and nk cell activators |
| 07/25/2007 | CN101003573A Human antibodies that bind human tnfalpha |
| 07/25/2007 | CN101003569A Antigen epitope and mutant of lyase in gamma bacteriophage of anthrax bacillus, and application |
| 07/25/2007 | CN101003566A Inhibition peptide in domain of polymerase protein of hepatitis b virus, and application |
| 07/25/2007 | CN101003550A Nucleotide compound in halogenating adenine class, synthetic method, medical appliction |
| 07/25/2007 | CN101003543A Anti infectious compound and usage |
| 07/25/2007 | CN101003542A Sterilization compound in broad spectrum and usage |
| 07/25/2007 | CN101003541A Antibacterial compound in broad spectrum and usage |
| 07/25/2007 | CN101003540A Anti infectious compound and usage |
| 07/25/2007 | CN101003539A Trometamol salt in compound of cillin category, and preparation method |
| 07/25/2007 | CN101003536A Entecavir salt, and preparation |
| 07/25/2007 | CN101003532A Method for producing antifungal drug in triazole class |
| 07/25/2007 | CN101003490A Chelated silver amino nitrate, preparation method and application |
| 07/25/2007 | CN101002973A Catheter with polymeric coating |
| 07/25/2007 | CN101002947A Target medicine used for treating bacteriosis, and its preparing method |
| 07/25/2007 | CN101002944A Conjugate of branched chair polymacrogol-interferon, and its preparing method |
| 07/25/2007 | CN101002938A Oral formulation containing itraconazole and methods for manufacturing and using the same |
| 07/25/2007 | CN101002936A Vaccine for preventing flavivirus infection |
| 07/25/2007 | CN101002929A Medicine for treating functional hypopepsia or complicating Helicobacter pylori infection, and its preparing method |
| 07/25/2007 | CN101002900A Plaster for detumescence and drawing out poison |
| 07/25/2007 | CN101002896A Method for preparing traditional Chinese medicine-fuganneng for treating liver diseases |
| 07/25/2007 | CN101002874A Compounding traditional Chinese medicine for antibiotic and anti-inflammatory, and its preparing method |
| 07/25/2007 | CN101002860A Oral medicine liquid for killing virus of hepatitis B, and its preparing method |
| 07/25/2007 | CN101002859A Compounding Herba Andrographitis dripping pills, and its preparing method |
| 07/25/2007 | CN101002849A Traditional Chinese medicine extractive or tablet for treating hepatitis, and its preparing method |
| 07/25/2007 | CN101002845A Oral medicine for treating hydrophobia, and its preparing method |
| 07/25/2007 | CN101002827A Micro-emulsion of mint oil with slow-releasing property, and its preparing method |
| 07/25/2007 | CN101002823A External use medicine for treating finger nail (ortoenail) mycosis |
| 07/25/2007 | CN101002821A Ointment for treating herpes |
| 07/25/2007 | CN101002807A Herba Andrographitis dripping pills for treating cold, and its preparing method |
| 07/25/2007 | CN101002806A Anti-influenza dripping pills containing cottonrose hibiscus leaf, and its preparing method |
| 07/25/2007 | CN101002801A Health-care food for enhancing immunity, and its preparing method |
| 07/25/2007 | CN101002798A Sterilizing nebula for treating foot diseases, and its preparing method |
| 07/25/2007 | CN101002790A Slow releace tablets of clarithromycin, and its preparing method |
| 07/25/2007 | CN101002786A Plaster for treating hepatitis B, and its preparing method |
| 07/25/2007 | CN101002783A Compound medicine for treating scabies |
| 07/25/2007 | CN101002782A Medicine composition containing ceftin cyclodextrin clathrate, and its preparing method |
| 07/25/2007 | CN101002781A Tablets of vacyclovir hydrochloride, and its preparing method |
| 07/25/2007 | CN101002779A Broad-spectrum antibiotic preparation |
| 07/25/2007 | CN101002778A Injection containing anti-infective, and its preparation method |
| 07/25/2007 | CN101002777A Injection solution containing anti-infective medicine |
| 07/25/2007 | CN101002776A Broad-spectrum antibiotic preparation |
| 07/25/2007 | CN101002775A Anti-inflective preparation |
| 07/25/2007 | CN101002774A Anti-inflammatory and sterilizing preparation |
| 07/25/2007 | CN101002767A Dispersion tablets of penicillin V potassium, and its preparing method |
| 07/24/2007 | USRE39743 Antibiotics, bactericides |
| 07/24/2007 | US7247712 Complex of hepatitis B virus-specific antigenic peptides associated with heat shock proteins and the application thereof |
| 07/24/2007 | US7247653 Pharmaceutical composition |
| 07/24/2007 | US7247648 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones |
| 07/24/2007 | US7247640 Comprises as an active ingredient a sulphostin-related compound such as 3(S)-amino-1-((S)-amino(sulfoamino)-phosphinyl)-2-piperidone |
| 07/24/2007 | US7247639 Xanthines 1-substituted with an alkyl group, 3-substituted with a phenylalkylene group and 8-substituted with an arylalkylene group, e.g. 3-[2-[4-(5-aminopentyl-3-amidocarboxypropanoyl)]aminophenyl]ethyl]-8-benzyl-7-[2-ethyl(2-hydroxyethyl)amino]ethyl-1-propylxanthine |
| 07/24/2007 | US7247634 Rifamycin derivatives effective against drug-resistant microbes |
| 07/24/2007 | US7247632 for treatment of microbial infections; potent inhibitors of (bMAP) bacterial aminopeptidase |
| 07/24/2007 | US7247626 prophylaxis and treatment of herpes viral infections; e.g. N-Cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(4-fluorophenyl)pyrazolo[1,5-c]pyrimidin-7-amine |
| 07/24/2007 | US7247622 Antibiotic; beta-lactamase inhibitor; therapy for infection |
| 07/24/2007 | US7247445 2-O sulfatase compositions and methods of hydrolyzing therewith |
| 07/24/2007 | US7247308 Vaccine; polynucleotide; generating antibodies |
| 07/24/2007 | US7247306 Bacteria strain and bacteriocin produced therefrom |
| 07/24/2007 | CA2479846C Phosphonomethoxymethylpurine/pyrimidine derivatives |
| 07/24/2007 | CA2188695C Pharmaceutical formulations containing a beta-lactamase inhibiting penem in combination with a beta-lactam antibiotic and their use in the treatment of bacterial infections |
| 07/24/2007 | CA2162134C Hepatitis-c virus type 4,5 and 6 |
| 07/24/2007 | CA2097019C Process for attenuated varicella zoster virus vaccine production |
| 07/19/2007 | WO2007081288A1 Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant |
| 07/19/2007 | WO2007081287A1 Immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant |
| 07/19/2007 | WO2007081031A1 Glycosyltransferase inhibitor |
| 07/19/2007 | WO2007081030A1 Pyrrolopyridazinone compound |
| 07/19/2007 | WO2007080874A1 Mutant gene fragment of glycopeptide-pooly-sensitive staphylococcus and use thereof |
| 07/19/2007 | WO2007080669A1 Antiviral/antiinflammatory drug composition |
| 07/19/2007 | WO2007080401A1 Triazoloanilinopyrimidine derivatives for use as antiviral agents |
| 07/19/2007 | WO2007080277A1 Method for preparing antibodies selective for activating fc receptors |
| 07/19/2007 | WO2007080203A1 Gene construct, vector and dna vaccine for the vaccination of aquatic animals |
| 07/19/2007 | WO2007079755A1 Reimmunization and antibody design |
| 07/19/2007 | WO2007079684A1 A mycobacterium tuberculosis fusion protein and uses thereof |
| 07/19/2007 | WO2007079653A1 OPTICALLY PURE α-SUBSTITUTED 2-METHYL-5-NITROIMIDAZOLE-1-ETHANOL DERIVATIVES |
| 07/19/2007 | WO2007079592A1 Protein c pathway associated polymorphisms as response predictors to activated protein c or protein c like compound administration |
| 07/19/2007 | WO2007079515A1 Mutilin derivatives and their use as pharmaceutical |
| 07/19/2007 | WO2007059356A3 Furfurylidene- pyrazolidines and their use as inhibitors of ubiquitin e1 |
| 07/19/2007 | WO2007031297A3 Use of cistus incanus extracts for the preparation of a medicament for the prevention and/or treatment of influenza |
| 07/19/2007 | WO2007017828A3 Oxazolidinone-quinolone hybrids as antibacterial compounds |
| 07/19/2007 | WO2007015824A3 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 07/19/2007 | WO2007015174A3 Exosome-specific ligands, their preparartion and uses |
| 07/19/2007 | WO2006130553A3 Hcv protease inhibitors |
| 07/19/2007 | WO2006037623A3 New nuclear transcription factors regulators |
| 07/19/2007 | US20070167627 Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate |
| 07/19/2007 | US20070167501 Bicyclo derivative |
| 07/19/2007 | US20070167495 Pleuromutilin derivatives, process for their preparation and uses thereof |
| 07/19/2007 | US20070167493 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation, therapeutic and cosmetic uses thereof |
| 07/19/2007 | US20070167481 Imidazonaphthyridines |
| 07/19/2007 | US20070167459 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 07/19/2007 | US20070167447 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase |
| 07/19/2007 | US20070167424 Aztreonam L-lysine and methods for the preparation thereof |
| 07/19/2007 | US20070167357 Dab9 DERIVATIVES OF LIPOPEPTIDE ANTIBIOTICS AND METHODS OF MAKING AND USING THE SAME |
| 07/19/2007 | US20070166790 Derivatives of magainin and methods of production thereof |
| 07/19/2007 | US20070166747 Methods for Measuring Therapy Resistance |
| 07/19/2007 | US20070166745 Screening and use of reagents which block or activate intein splicing utilizing natural or homologous exteins |
| 07/19/2007 | US20070166701 Methods for detecting flavivirus infection |
| 07/19/2007 | US20070166330 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS |
| 07/19/2007 | US20070166329 Containing transcriptional units which encode a signal sequence of one flavivirus and an immunogenic flavivirus antigen of a second flavivirus; Japanese encephalitis virus (JEV), West Nile virus (WNV) or related flaviviruses |
| 07/19/2007 | US20070166286 Self-rearranging DNA vectors |